[Characteristics of liver volume and pathological changes with different stages of liver fibrosis in chronic liver disease].

Zhonghua Gan Zang Bing Za Zhi

Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai 201203, China Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai 201203, China.

Published: June 2024

To measure the overall and lobulated volume of the liver with different degrees of liver fibrosis and to further observe pathological changes such as liver microvasculature, hepatocyte apoptosis, and regeneration in order to understand the macroscopic volume changes of the liver during liver fibrosis and its relationship with liver tissue microscopic pathology in patients with chronic liver disease. 53 patients with chronic hepatitis B, alcoholic fatty liver disease, autoimmune liver disease, nonalcoholic fatty liver disease, and drug-induced chronic liver disease who underwent both liver biopsy tissue and abdominal magnetic resonance imaging were collected. Patients were divided into early (F1-2), middle (F3-4), and late (F5-6) in accordance with the Ishak fibrosis stage and Masson stain. The liver and spleen volumes were measured using ITK-SNAP software. CD31 immunohistochemical staining was used to reflect intrahepatic angiogenesis. Ki67 and HNF-4α multiplex immunohistochemical staining were used to reflect hepatocyte regeneration. GS staining was used to determine parenchymal extinction lesions. TUNEL staining was used to observe hepatocyte apoptosis. Spearman correlation analysis was used to analyze the relationship between liver volume changes and liver histopathological changes. As liver fibrosis progressed, the total liver volume and right lobe liver volume gradually decreased (<0.05), while the spleen volume gradually increased (<0.05). The expression of CD31 and GS gradually increased (<0.05), and the expression of Ki67 first increased and then decreased (<0.05). The positivity rate of CD31 was negatively correlated with the right lobe liver volume (=-0.609, <0.001) and the total liver volume (=-0.363, =0.017). The positivity rate of Ki67 was positively correlated with the right lobe liver volume (=0.423, =0.018), while the positivity rate of apoptotic cells was significantly negatively correlated with the total liver volume (=-0.860, <0.001). The positivity rate of GS was negatively correlated with the right lobe liver volume (=-0.440, =0.002), and the number of PELs was negatively correlated with RV (=-0.476, =0.013). The CD31 positive staining area was negatively correlated with the Ki67 positive staining area(=-0.511, =0.009). As liver fibrosis progresses, patients with chronic liver disease have a depletion in total liver volume and right lobe liver volume, and this is mainly in correlation with fewer liver cells and liver tissue microvasculature disorders.

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.cn501113-20231219-00286DOI Listing

Publication Analysis

Top Keywords

liver
20
liver disease
20
liver volume
16
liver fibrosis
16
changes liver
16
chronic liver
12
pathological changes
8
hepatocyte apoptosis
8
volume changes
8
relationship liver
8

Similar Publications

Background: International guidelines give greatly varying definitions of 25-hydroxyvitamin D (25OHD) insufficiency and deficiency. Vitamin D testing is increasing despite 2016 UK guidance for adults advising routine vitamin D supplementation October-March and year-round for high risk groups. A service evaluation of vitamin D testing and biochemical osteomalacia in the North-East of Scotland (57-58°N) could inform definitions and testing guidance.

View Article and Find Full Text PDF

Background: Mycobacterium avium complex (MAC) is a common pathogen causing non-tuberculous mycobacterial infections, primarily affecting the lungs. Disseminated MAC disease occurs mainly in immunocompromised individuals, such as those with acquired immunodeficiency syndrome, hematological malignancies, or those positive for anti-interferon-γ antibodies. However, its occurrence in solid organ transplant recipients is uncommon.

View Article and Find Full Text PDF

Background: Hepatocellular carcinoma (HCC) associated with major vasculature tumor extension is considered an advanced stage of disease to which palliative radiotherapy or chemotherapy is proposed. Surgical resection associated with chemotherapy or chemoembolization could be an opportunity to improve overall survival and recurrence-free survival in selected cases in a high-volume hepatobiliary center. Moreover, it has been 25 years since Couinaud described the entity of a posterior liver located behind an axial plane crossing the portal bifurcation.

View Article and Find Full Text PDF

Objectives: Liver transplant (LT) is an effective treatment for hepatocellular carcinoma (HCC) in appropriately selected patients. Locoregional therapy (LRT) is often performed to extend a patient's eligibility for LT. Imaging has a modest sensitivity of approximately 40-77% for detecting pathologically viable HCC in post-LRT patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!